New Age Alpha Advisors LLC bought a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 21,922 shares of the company's stock, valued at approximately $1,407,000.
A number of other hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. raised its stake in Ryan Specialty by 107.5% during the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company's stock valued at $30,504,000 after purchasing an additional 238,064 shares in the last quarter. Bar Harbor Wealth Management raised its position in shares of Ryan Specialty by 5.9% during the 4th quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company's stock valued at $10,835,000 after buying an additional 9,482 shares in the last quarter. Barclays PLC raised its position in shares of Ryan Specialty by 1.1% during the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock valued at $108,994,000 after buying an additional 17,267 shares in the last quarter. Teachers Retirement System of The State of Kentucky grew its position in Ryan Specialty by 51.5% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 30,760 shares of the company's stock worth $2,042,000 after acquiring an additional 10,460 shares in the last quarter. Finally, HighTower Advisors LLC increased its stake in Ryan Specialty by 101.6% during the third quarter. HighTower Advisors LLC now owns 39,969 shares of the company's stock worth $2,661,000 after acquiring an additional 20,139 shares during the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In related news, Director Nicholas Dominic Cortezi sold 29,466 shares of the business's stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the completion of the transaction, the director now owns 45,409 shares in the company, valued at $2,954,309.54. The trade was a 39.35 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 241,360 shares of company stock worth $16,006,428. 11.10% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on the company. UBS Group increased their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a report on Wednesday, February 26th. Morgan Stanley initiated coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 target price for the company. Keefe, Bruyette & Woods dropped their price target on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a research note on Friday, February 21st. Royal Bank of Canada reduced their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. Finally, Wells Fargo & Company boosted their target price on Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a research report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Ryan Specialty has an average rating of "Hold" and a consensus target price of $75.27.
Read Our Latest Report on RYAN
Ryan Specialty Stock Up 1.8 %
Shares of RYAN stock traded up $1.33 on Wednesday, hitting $75.14. The stock had a trading volume of 1,360,986 shares, compared to its average volume of 932,904. Ryan Specialty Holdings, Inc. has a one year low of $48.48 and a one year high of $78.67. The business has a 50 day moving average price of $69.03 and a 200 day moving average price of $68.46. The company has a market cap of $19.68 billion, a PE ratio of 108.90, a P/E/G ratio of 1.19 and a beta of 0.71. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). The business had revenue of $663.53 million during the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were issued a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.64%. Ryan Specialty's dividend payout ratio (DPR) is currently 69.57%.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Stories

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report